399 THORNALL STREET, EDISON, NJ
Board Appointment - Danina Fisher and Gary S. Stetz, II Join Directors
Hepion Pharmaceuticals 2026 Annual Meeting Results; Directors Elected
Annual Report to Security Holders
Hepion Pharmaceuticals Enters $700,000 Securities Purchase Agreement
Material disclosure
CEO Resignation - Dr. Kaouthar Lbiati Steps Down at Hepion Pharmaceuticals
News
CEO Appointment - Dr. Kaouthar Lbiati Joins Hepion Pharmaceuticals
Q1
Q3
Q2
Notice of Late Filing for Quarterly Report
FY 2024
Notice of Late Filing for Annual Report
Amended Annual Report
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Prospectus Filed Pursuant to Rule 425
Definitive Proxy Statement
PRER14A
PRE 14A
Additional Proxy Materials
Initial Statement of Beneficial Ownership
Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Submission Upload
S-1MEF